BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4545538)

  • 21. Cutaneous and subcutaneous necrosis as a complication of coumarin-congener therapy.
    Kahn S; Stern HD; Rhodes GA
    Plast Reconstr Surg; 1971 Aug; 48(2):160-6. PubMed ID: 5561891
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of anticoagulation in patients with acute gastrointestinal bleeding.
    Radaelli F; Dentali F; Repici A; Amato A; Paggi S; Rondonotti E; Dumonceau JM
    Dig Liver Dis; 2015 Aug; 47(8):621-7. PubMed ID: 25935464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulant therapy in right-sided thromboembolic disease.
    Robin ED; Burke CM
    Chest; 1986 Jun; 89(6):882-4. PubMed ID: 3519111
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulant therapy for venous thromboembolism.
    Raskob GE; Carter CJ; Hull RD
    Prog Hemost Thromb; 1989; 9():1-27. PubMed ID: 2643814
    [No Abstract]   [Full Text] [Related]  

  • 25. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant treatment of venous thromboembolism.
    Coon WW
    Surg Annu; 1972; 4():151-63. PubMed ID: 4668856
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombotic complications following the administration of high-dose prothrombin complex concentrate for acute warfarin reversal.
    Zemrak WR; Kelley E; Kovacic NL; Mooney DM; Morris JG; MacVane CZ; Rosenblatt JA
    Am J Emerg Med; 2016 Aug; 34(8):1736.e1-3. PubMed ID: 26806175
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible interaction between ciprofloxacin and warfarin.
    Kamada AK
    DICP; 1990 Jan; 24(1):27-8. PubMed ID: 2301186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemorrhagic diverticulosis: demonstration of source of bleeding.
    Ho KJ
    Arch Pathol Lab Med; 1977 Feb; 101(2):106. PubMed ID: 300012
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of left atrial ball thrombus during anticoagulation in a case of cerebral embolism.
    Tsuda Y; Satoh K; Matsuo H; Maeta H
    Stroke; 1990 Sep; 21(9):1375-6. PubMed ID: 2396277
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report.
    Rankin J; Nagar M; Crosby J; Toomari N; Pietras R; Ben-Zur UM
    J Med Case Rep; 2016 Dec; 10(1):346. PubMed ID: 27912791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombolytic therapy].
    Schmutzler R; Koller F
    Ergeb Inn Med Kinderheilkd; 1965; 22():157-210. PubMed ID: 5889464
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of pulmonary embolism in patients with fractures of the femoral neck.
    Burcharth F; Hansen OH; Wolf H; Ostergaard AH
    Acta Chir Scand Suppl; 1973; 433():178-9. PubMed ID: 4541046
    [No Abstract]   [Full Text] [Related]  

  • 36. Limb-threatening Deep Venous Thrombosis Complicating Warfarin Reversal with Three-factor Prothrombin Complex Concentrate: A Case Report.
    Jablow LM; Jones CW; Carroll GG; Wilsey SV; Haroz R
    J Emerg Med; 2016 Jan; 50(1):28-31. PubMed ID: 26603365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spontaneous intramural hematoma of the small bowel due to use of oral anticoagulants: case report and review of the literature].
    Reyes Garay H; Tagle Arróspide M
    Rev Gastroenterol Peru; 2010; 30(2):158-62. PubMed ID: 20644609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral anticoagulants in clinical practice.
    Brozović M
    Semin Hematol; 1978 Jan; 15(1):27-34. PubMed ID: 622584
    [No Abstract]   [Full Text] [Related]  

  • 39. Management and Outcomes of Bleeding Events in Patients in the Emergency Department Taking Warfarin or a Non-Vitamin K Antagonist Oral Anticoagulant.
    Singer AJ; Quinn A; Dasgupta N; Thode HC
    J Emerg Med; 2017 Jan; 52(1):1-7.e1. PubMed ID: 27793500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparison of the Rate of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin.
    Cangemi DJ; Krill T; Weideman R; Cipher DJ; Spechler SJ; Feagins LA
    Am J Gastroenterol; 2017 May; 112(5):734-739. PubMed ID: 28244496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.